CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The InCanTeSiMo project focuses on developing synthetic circuits for targeted cancer therapy. By encapsulating these circuits in protective vehicles, the project aims to deliver and activate treatments specifically at cancer sites, minimizing side effects and personalizing therapy based on individual patient profiles.
With InCanTeSiMo I aim to realize local delivery and activation of cancer-defeating synthetic circuits.
Despite the advent of immunotherapy as promising treatment against a number of cancers, surgery, radio- or chemotherapy, alone or in combination, remain the most common interventions.
While surgery and radiotherapy are mainly targeted to the cancer itself, chemotherapy has a systemic mode of action, affecting both healthy as well as diseased cells.
An innovative way to fight cancer would be th…
ALBERT-LUDWIGS-UNIVERSITAET FREIBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
